An industry-funded conservative policy group known for delivering model bills to Republican lawmakers recently urged an audience of state legislators [...] …
Year: 2024
Two major national 340B provider advocacy groups are stepping up their criticisms of the 340B ACCESS Act, arguing that the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The federal agency tasked with overseeing the 340B program will review and release some of the 340B-related records the New [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
After six months of heated battles in the states to restore access to 340B drug discounts in the contract pharmacy [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two 340B hospitals urged a federal district court to block drugmaker Johnson & Johnson (J&J) from conducting “unlawfully authorized” audits [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
New Jersey-based drug manufacturing giant Merck and a large Wisconsin-based health system are the latest to join the 340B Working [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A well-known candidate in a tightly contested Missouri Republican gubernatorial primary has called to “repeal 340B in Missouri” after the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A key Republican lawmaker accused executives of the three largest pharmacy benefit managers (PBMs) of “abusing” the 340B program during [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Just days after a federal court in Mississippi denied Novartis’ attempt to block the state’s 340B contract pharmacy access law, [...] …